Open Label Phase I Trial of intramyocardial AMG0001-01 administration in chronic heart failure patients with ischemic cardiomyopathy
Not Applicable
- Conditions
- chronic heart failure
- Registration Number
- JPRN-UMIN000012942
- Lead Sponsor
- osaka university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
patient implanted with an LVAD thickness of left ventricular wall<5mm severe pulmonary hypertension
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method frequency of adverse event incidence for adverse event
- Secondary Outcome Measures
Name Time Method